Organogenesis Holdings Inc. (FRA:2PQ)
Germany · Delayed Price · Currency is EUR 3.340
+0.020 (0.60%)
At close: Jan 30, 2026
Organogenesis Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 464.62 | 482.04 | 433.14 | 450.89 | 467.36 | 338.3 |
Other Revenue | 0.6 | - | - | - | - | - |
| 465.22 | 482.04 | 433.14 | 450.89 | 467.36 | 338.3 | |
Revenue Growth (YoY) | 2.24% | 11.29% | -3.94% | -3.52% | 38.15% | 29.63% |
Cost of Revenue | 118.66 | 115.74 | 106.48 | 105.02 | 114.2 | 87.32 |
Gross Profit | 346.56 | 366.3 | 326.66 | 345.87 | 353.16 | 250.98 |
Selling, General & Admin | 299.4 | 294.51 | 265.96 | 281.54 | 249.48 | 203.37 |
Research & Development | 45.79 | 50.27 | 44.38 | 39.76 | 30.74 | 20.09 |
Operating Expenses | 345.19 | 344.78 | 310.34 | 321.3 | 280.22 | 223.46 |
Operating Income | 1.38 | 21.52 | 16.32 | 24.57 | 72.94 | 27.52 |
Interest Expense | - | -1.54 | -2.19 | -2.01 | -7.24 | -11.28 |
Interest & Investment Income | 2.11 | - | - | - | - | - |
Other Non Operating Income (Expenses) | 0.07 | 0.02 | 0.06 | -0.01 | -0.01 | 0.1 |
EBT Excluding Unusual Items | 3.55 | 19.99 | 14.19 | 22.55 | 65.69 | 16.34 |
Merger & Restructuring Charges | -0.52 | - | -3.8 | -2.27 | -4.7 | -0.62 |
Gain (Loss) on Sale of Assets | -9.24 | - | - | - | - | - |
Asset Writedown | - | -22.8 | - | - | - | - |
Other Unusual Items | - | - | - | - | 2.1 | 2.04 |
Pretax Income | -6.2 | -2.81 | 10.39 | 20.28 | 63.09 | 17.76 |
Income Tax Expense | -7.21 | -3.67 | 5.45 | 4.75 | -31.12 | 0.53 |
Earnings From Continuing Operations | 1.01 | 0.86 | 4.95 | 15.53 | 94.2 | 17.23 |
Net Income | 1.01 | 0.86 | 4.95 | 15.53 | 94.2 | 17.23 |
Preferred Dividends & Other Adjustments | 10.23 | 1.8 | - | - | - | - |
Net Income to Common | -9.23 | -0.94 | 4.95 | 15.53 | 94.2 | 17.23 |
Net Income Growth | - | -82.59% | -68.16% | -83.51% | 446.61% | - |
Shares Outstanding (Basic) | 127 | 132 | 131 | 130 | 128 | 108 |
Shares Outstanding (Diluted) | 127 | 132 | 133 | 132 | 134 | 111 |
Shares Change (YoY) | -3.51% | -0.81% | 0.27% | -0.96% | 20.03% | 19.95% |
EPS (Basic) | -0.07 | -0.01 | 0.04 | 0.12 | 0.73 | 0.16 |
EPS (Diluted) | -0.08 | -0.01 | 0.04 | 0.12 | 0.70 | 0.15 |
EPS Growth | - | - | -68.44% | -82.94% | 366.67% | - |
Free Cash Flow | -51.65 | 4.18 | 6.55 | -9.04 | 30.76 | -12.21 |
Free Cash Flow Per Share | -0.41 | 0.03 | 0.05 | -0.07 | 0.23 | -0.11 |
Gross Margin | 74.50% | 75.99% | 75.42% | 76.71% | 75.56% | 74.19% |
Operating Margin | 0.30% | 4.46% | 3.77% | 5.45% | 15.61% | 8.13% |
Profit Margin | -1.98% | -0.19% | 1.14% | 3.45% | 20.16% | 5.09% |
Free Cash Flow Margin | -11.10% | 0.87% | 1.51% | -2.00% | 6.58% | -3.61% |
EBITDA | 19.56 | 38.54 | 31.69 | 35.3 | 83.67 | 35.7 |
EBITDA Margin | 4.20% | 8.00% | 7.32% | 7.83% | 17.90% | 10.55% |
D&A For EBITDA | 18.18 | 17.03 | 15.37 | 10.73 | 10.73 | 8.18 |
EBIT | 1.38 | 21.52 | 16.32 | 24.57 | 72.94 | 27.52 |
EBIT Margin | 0.30% | 4.46% | 3.77% | 5.45% | 15.61% | 8.13% |
Effective Tax Rate | - | - | 52.41% | 23.42% | - | 2.98% |
Advertising Expenses | - | 3.83 | 5.23 | 4.81 | 5.52 | 2.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.